Oliver Zill
6PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 19, 2023
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types.Hem R Gurung, Amy J Heidersbach, Martine Darwish
|Sep 18, 2022
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.Radia M Johnson, Xueping Qu, Chu-Fang Lin
|Aug 18, 2022
Single-cell analysis reveals clonally expanded tumor-associated CD57+ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade.Michael Fehlings, Leesun Kim, Xiangnan Guan
|Mar 17, 2022
Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma.Andrew Wallace, Sima P Porten, Amy A Lo
|Oct 02, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies.Amy A Lo, Andrew Wallace, Daniel Oreper
|Jun 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor types.Romain Banchereau, Ning Leng, Oliver Zill
Pageof 1
Frequent Collaborators
2 joint publications
Amy A Lo
1 joint publications
Michael Fehlings
1 joint publications
Alireza Tafazzol
1 joint publications
Evan W Newell
1 joint publications
Mahesh Yadav
1 joint publications
Radia M Johnson
1 joint publications
Xueping Qu
1 joint publications
Fang-Shu Ou
1 joint publications
Richard Bourgon
1 joint publications
Felipe de Sousa E Melo
